| 摘要 |
A process for treating a protozoan disease, for example, malaria, by the systemic administration to a subject hosting a malarial parasite of the 3-(5'-ribonucleotide) of a novel analog of the well-known antibiotics lincomycin and clindamycin. The analogs are prepared by condensing a cyclic acid with a sugar amine. The 3-ribonucleotides of these analogs can be prepared by microbiological transformation procedures. |
